MDEChem, Inc. (MDKM)
MDEChem, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in Floresville, TX, US. The stock last traded at $0.00, down 100.00% on the session, giving a market capitalisation of $630. Its beta of -28.87 implies it has historically moved less than the broad market.
MDEChem, Inc., established in 1996 and operating from Floresville, Texas, is a developer and supplier of pharmaceutical and chemical products. Among its key offerings is MaxHeal, an anti-inflammatory, non-steroidal skin restoration gel designed to deliver rapid comfort for minor cuts, scrapes, superficial burns (including sunburn), and abrasions. This gel also effectively soothes the itch and irritation caused by insect bites from pests such as chiggers, mosquitoes, sand fleas, black flies, and other biting insects. Furthermore, the company provides SANDKLENE 950, a non-toxic chemical solution crucial for the efficient recovery of oil from tar and oil sands.
MDEChem, Inc. is most often compared with the following Healthcare names: